The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of immune activation following neoadjuvant sipuleucel-T in subjects with localized prostate cancer.
Nadeem A. Sheikh
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Johnna D. Wesley
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Nikole Perdue
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Frances P. Stewart
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Lawrence Fong
Research Funding - Dendreon